A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
使用双向短信监测和治疗高血压的药剂师干预
基本信息
- 批准号:10477383
- 负责人:
- 金额:$ 66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Ambulatory Blood Pressure MonitoringBlood PressureCardiovascular DiseasesCaringCause of DeathCellular PhoneCessation of lifeClinicClinicalClinical PharmacistsClinical Pharmacy ServiceCollaborationsControl GroupsCustomDiagnosisDisciplineEffectiveness of InterventionsElderlyFundingGoalsHealthHealth PersonnelHealthcareHomeHome Blood Pressure MonitoringHourHypertensionImprove AccessInterventionInvestmentsKnowledgeManaged CareMeasurementMedicalModelingMonitorMorbidity - disease rateMyocardial InfarctionNational Heart, Lung, and Blood InstitutePaperPatientsPharmacistsPhysician ExecutivesPhysiciansPhysicians&apos OfficesPrimary Health CarePrivatizationProviderReadingResearchResourcesRiskRuralRural PopulationServicesSmokingStrokeTechnologyText MessagingTimeWorkadherence ratebaseblood pressure controlblood pressure reductioncostcost effectivecost effectivenessfollow-upgroup interventionhypertension controlimprovedmedically underserved populationmembermortalitynovelpreventpublic health relevancerural arearural dwellersrural patientstelehealthtwo way textingvirtualweb based interface
项目摘要
ABSTRACT
Hypertension causes an estimated 395,000 deaths in the US each year: one out of every six deaths.
Hypertension is second only to smoking as a modifiable cause of death in the US. Poor blood pressure (BP)
control increases the risk of myocardial infarction, stroke and death and is often due to delays in treatment
intensification. We have developed a telehealth service called Centralized Healthcare Solutions that has
successfully delivered clinical pharmacy services remotely to private physician offices, especially in small
medical offices and rural locations. In our prior work, we demonstrated that a physician-pharmacist
collaboration could cost effectively reduce BP, but pharmacists spent a considerable proportion of their time
obtaining and aggregating patients' home BP measurements. Thus, we have developed an additional m-
health solution called What's your BP? (WyBP), a custom- built bi-directional SMS-based (short message
service, or texting) platform. WyBP is inexpensive (i.e., does not require investment in smartphone
technology, or WiFi), acceptable to a broad range of patients (including the elderly and rural populations),
scalable to subject volume observed in busy clinical settings, and easily integrated into typical clinic
workflows. In two pilots, we demonstrated a high rate of adherence, indicating that patients were willing and
able to take home BP measurements and send them to our research team. This proposal combines our two
prior efforts to use remotely located pharmacists and bi-directional texting to improve efficiencies, reduce
cost and improve access to a dedicated pharmacist. A major gap in our knowledge is whether the potency
of a “virtual” team member can be improved by home BP monitoring with technological support, especially
in small medical offices. The goal of this proposal is to evaluate whether our scalable SMS approach
combined with a pharmacist-based intervention improves BP management cost effectively. To achieve this
objective, we will determine if our intervention leads to decreases in BP; determine if our intervention leads
to intensification of therapy; and determine the cost effectiveness of the intervention. At the end of this
project, we expect to provide a novel, scalable and cost-effective approach for treating hypertension in rural
populations by expanding the feasibility, scalability and dissemination of the Centralized Healthcare
Solutions intervention. The intervention has important
抽象的
据估计,美国每年有 395,000 人死于高血压:六分之一的人死于高血压。
在美国,高血压是仅次于吸烟的第二大可改变的死亡原因。
控制不当会增加心肌梗死、中风和死亡的风险,通常是由于治疗延误造成的
我们开发了一种称为集中医疗解决方案的远程医疗服务。
成功向私人医生办公室远程提供临床药学服务,特别是在小型诊所
在我们之前的工作中,我们证明了医生兼药剂师。
合作可以有效地降低血压,但药剂师花费了相当大的时间
获取并汇总患者的家庭血压测量结果因此,我们开发了额外的 m-。
名为“你的血压是多少?”(WyBP)的健康解决方案,是一种基于短信的定制双向短信
WyBP 服务或短信)平台价格低廉(即不需要投资智能手机)。
技术或 WiFi),为广泛的患者(包括老年人和农村人口)所接受,
可根据繁忙临床环境中观察到的受试者量进行扩展,并轻松集成到典型诊所中
在两个试点中,我们表现出了很高的依从率,这表明患者愿意并且愿意。
能够将血压测量值带回家并发送给我们的研究团队 该提案结合了我们的两个。
在使用远程药剂师的努力和双向短信之前,可以提高效率,减少
我们知识的一个主要差距是药效是否有效。
在技术支持下,可以通过家庭血压监测来改善“虚拟”团队成员的健康状况,尤其是
该提案的目标是评估我们的 SMS 方法是否可扩展。
与基于药剂师的干预相结合,可以有效地提高血压管理成本,以实现这一目标。
目标,我们将确定我们的干预是否会导致血压下降;
强化治疗;并在结束时确定干预措施的成本效益。
项目,我们希望为农村地区的高血压治疗提供一种新颖、可扩展且具有成本效益的方法
通过扩大集中医疗保健的可行性、可扩展性和传播来惠及人口
解决方案的干预具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barry L Carter其他文献
Barry L Carter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barry L Carter', 18)}}的其他基金
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
使用双向短信监测和治疗高血压的药剂师干预
- 批准号:
10685296 - 财政年份:2019
- 资助金额:
$ 66万 - 项目类别:
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
使用双向短信监测和治疗高血压的药剂师干预
- 批准号:
10026334 - 财政年份:2019
- 资助金额:
$ 66万 - 项目类别:
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
使用双向短信监测和治疗高血压的药剂师干预
- 批准号:
10251128 - 财政年份:2019
- 资助金额:
$ 66万 - 项目类别:
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
改善心血管风险降低以加强农村初级保健:I-CARE
- 批准号:
8716808 - 财政年份:2013
- 资助金额:
$ 66万 - 项目类别:
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
改善心血管风险降低以加强农村初级保健:I-CARE
- 批准号:
9115222 - 财政年份:2013
- 资助金额:
$ 66万 - 项目类别:
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
改善心血管风险降低以加强农村初级保健:I-CARE
- 批准号:
8576979 - 财政年份:2013
- 资助金额:
$ 66万 - 项目类别:
A collaborative model to improve BP control and minimize racial disparities-CCC
改善血压控制并尽量减少种族差异的协作模式-CCC
- 批准号:
7578145 - 财政年份:2009
- 资助金额:
$ 66万 - 项目类别:
A collaborative model to improve BP control and minimize racial disparities-CCC
改善血压控制并尽量减少种族差异的协作模式-CCC
- 批准号:
8067075 - 财政年份:2009
- 资助金额:
$ 66万 - 项目类别:
A collaborative model to improve BP control and minimize racial disparities-CCC
改善血压控制并尽量减少种族差异的协作模式-CCC
- 批准号:
8435506 - 财政年份:2009
- 资助金额:
$ 66万 - 项目类别:
A collaborative model to improve BP control and minimize racial disparities-CCC
改善血压控制并尽量减少种族差异的协作模式-CCC
- 批准号:
8242762 - 财政年份:2009
- 资助金额:
$ 66万 - 项目类别:
相似国自然基金
胆汁酸通过TRPC3调控血管平滑肌钙稳态改善高血压的机制
- 批准号:32371166
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肾副交感神经通过肾素-血管紧张素系统对血压的调控作用及机制
- 批准号:82300503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GGTase-I调节平滑肌细胞衰老和刚度在动脉僵硬及老年高血压中的作用机制研究
- 批准号:82370428
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于MLCK/p-MLC通路研究DAPK1调控高血压的新机制及清达颗粒的干预作用
- 批准号:82304758
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
清达颗粒对Rab5a介导AMPK/PPARα通路调控脂质代谢稳态参与高血压心肌能量代谢重编程的影响研究
- 批准号:82374359
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Investigation of Sex Differences in Physical Activity and its Relationships with Stress After Myocardial Infarction
心肌梗死后体力活动的性别差异及其与应激的关系调查
- 批准号:
10751366 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别:
A Smart Ring for Cuffless Blood Pressure to Reduce Health Disparities in People of Color
用于无袖血压测量的智能环,可减少有色人种的健康差异
- 批准号:
10720348 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别:
Chrono-exercise is Medicine: Improving Blood Pressure and Vascular Function through Chronotherapy
计时运动是良药:通过计时疗法改善血压和血管功能
- 批准号:
10658613 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别:
Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT)
儿童:肾小球疾病、高血压和转录组学的夜间调查 (kNIGHT)
- 批准号:
10583680 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别:
A novel instrument for continuous blood pressure monitoring
一种新型连续血压监测仪器
- 批准号:
10696510 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别: